In order to identify novel genes expressed in skeletal muscle we performed a subtractive hybridization for genes expressed in human skeletal muscle but not in other tissues. We identified a novel scalloped interaction domain (SID) containing protein in humans and in the mouse, which we named VITO-1. Highest homology of VITO-1 was found with the Drosophila vestigial and the human TONDU proteins in the SID (54 and 40%, respectively). Using whole-mount hybridzation and Northern blot analysis, we showed that VITO-1 is expressed in the somitic myotome from E8.75 mouse embryos onwards and later on in skeletal muscle but not in the heart. Additional expression domains during development were detected in the pharyngeal pouches and clefts starting at E8.0 as well as in the cranial pharynx and in Rathkes pouch. By Northern blot analysis, we found VITO-1 to be up-regulated in C2C12 myotubes although some expression can be detected in proliferating C2C12 myoblasts. No expression was spotted in other adult mouse tissues. Likewise, expression of human Vito-1 during fetal and adult human development was found exclusively in skeletal muscle preferentially in fast skeletal muscles. These data suggest a role of VITO-1 for the development of skeletal muscles and of pharyngeal clefts/Rathkes' pouch derived structures. q
Results and discussion
The DNA-binding specificity of transcription factors as well as other biochemical properties are often modulated by cooperative interactions with specific co-factors (McKenna and O'Malley, 2002) . In Drosophila, the vestigial (Vg) protein interacts via the scalloped interaction domain (SID) with scalloped (Sd) and binds to DNA through the Sd TEA/ATTS region (Halder and Carroll, 2001 ). The SdVg complex is a master regulator of wing development, which controls various targets genes and is able to induce ectopic wing outgrowth (Halder et al., 1998) . Sd is the Drosophila homologue of the vertebrate transcription enhancer factor (TEF) family of transcription factors that contains a TEA DNA-binding domain (Jacquemin et al., 1996; Simmonds et al., 1998) . In vertebrates, molecules such as human TONDU and mouse vestigial related have been identified that share similarities in the SID to vestigial (Fig. 1) . Significantly, conservation of the functional SID during evolution is sufficient to mediate interaction of vertebrate TEF factors with Drosophila Sd and to substitute for Vg in Drosophila wing formation (Vaudin et al., 1999; Srivastava et al., 2002) .
We have isolated a new SID containing protein by using a subtractive hybridization approach for genes expressed in human skeletal muscle but not in other tissues. Due to its similarity to the SID found in Drosophila vestigial and human TONDU we named this protein . Surprisingly, VITO-1 is more similar to Drosophila vestigial than to human TONDU, which might indicate a closer functional relationship of both proteins. Subsequent screening of a mouse embryonic cDNA library with a probe derived from hVITO-1 yielded a mRNA with a 82% similarity to hVITO-1 at the amino acid level. Due to the high degree of similarity to the human cDNA sequence (Fig. 1 ) and the identical gene structure (unpublished observations) we reason that this gene represents the mouse homologue of hVITO-1. To begin to unveil the role of VITO-1 for development, cell differentiation and tissue specific transcriptional activation we determined the expression of VITO-1 in various human and mouse tissues and at different stages of mouse development.
Northern blot analysis revealed the presence of a 2.5 kb mRNA product in the developing mouse embryo at E12.5, E14.5 and E17.5 and in newborn mice at P1. A strong . Northern blot analysis of human and mouse tissues. Northern blots containing 30 mg of total RNA isolated from various mouse (A); and human tissues, cells and developmental stages (B) were hybridized to random primed P 32 -labeled human and mouse VITO-1 probes, respectively. Expression was observed from developmental stages E12.5 to P1 of the mouse, in adult skeletal muscle of human and mouse origin and in undifferentiated and differentiated mouse C2C12 cells. No expression was found in heart muscles of either species. (A) 1-4. various developmental stages from E12.5 to postnatal day 1, 5. adult heart, 6. adult brain, 7. adult kidney, 8. adult skeletal muscle, 9. undifferentiates mouse C2C12 cells, 10. differentiated C2C12 myotubes. (B) 1. fetal ventricle, 2. fetal atrium, 3. fetal skeletal muscle, 4. adult gastrocnemius muscle, 5. adult soleus muscle, 6. fetal kidney, 7. fetal liver, 8. fetal thymus, 9. fetal brain. Fig. 3 . Whole-mount in situ hybridization of mVITO-1 and Vibratome sections of hybridized mouse embryos at E8.0 to E9.5. Whole-mount preparations (A, C, E) and Vibratome sections are shown (B, D, F-L). Sections in B, D, G and H were prepared in the frontal plane as indicated by arrows. Sections in F, I-L were prepared in the transversal plane. The section in B is slightly tilted. Sections in G-K are arranged in a cranial to caudal order. Expression is apparent in the I and II branchial arch at E8.0 and E8.5 (A-D). At E9.5 VITO-1 is expressed in Rathkes pouch (F) and in derivatives of the cranial pharynx (I-K). The expression in somites is restricted to the myotome (L). ba, branchial arch; h, heart; nt, neural tube; max, maxilla part of the I ba; mad, mandibular part of the I ba, ph, pharynx; aos, aortic sac; and s, somite. mVITO-1 hybridization signal was found in adult skeletal muscle but not in heart muscle, brain or kidney. In addition, we detected mVITO-1 transcripts in proliferating C2C12 cells indicating expression of the gene in dividing myoblasts that have not yet undergone terminal differentiation although the expression level in C2C12 myoblasts. was lower compared to differentiated C2C12 myotubes ( Fig.  2A) . Similarly, a VITO-1 transcript of approximately the same size as in the mouse was detected in human fetal and adult skeletal muscle but not in fetal heart ventricle, heart atrium, brain, liver, kidney and thymus (Fig. 2B) . Interestingly, the expression of hVITO-1 was significantly higher in adult fast skeletal muscle (m. gastrocnemius) compared to a predominantly slow skeletal muscle (m. soleus).
To determine the cellular source of VITO-1 mRNA, we performed an in situ hybridization analysis using staged mouse embryos. At E8.0 strong expression of VITO-1 was found in the first and second branchial arches adjacent to the respective pharyngeal pouches and in the epithelium of the pharyngeal clefts (Figs. 3A,B) . At E8.5 the initial expression domains became more restricted and a new area of expression arose in the mesenchyme of the second branchial arch (Figs. 3C,D) . Expression in the maxillary and Fig. 4 . Whole-mount in situ hybridization of mVITO-1 and Vibratome sections of hybridized mouse embryos at E10.5 and E11.5. Whole-mount preparations (A, G) and Vibratome sections are shown (B-FD, H-I). Sections were prepared in the transversal plane as indicated by arrows. Expression is apparent in the I and II branchial arch (B, C); and in restricted areas of the cranial pharynx (D). The expression in somites at E10.5 (E); and E11.5 (H) is still restricted to the myotome. At E10.5 (F); and E11.5 (I) expression is found in the prospective muscle forming areas of the fore limb. ba, branchial arch; nt, neural tube; max, maxilla part of the I ba; mad, mandibular part of the I ba, ph, pharynx; s, somite; and fl, fore limb. mandibular component of the first branchial arch (Fig. 3G) as well as in the second branchial arch (Fig. 3H) was also noted at E9.5 when both components of the first branchial arch are well separated (Fig. 3G) . Sections taken more caudally (indicated in Fig. 3E by white arrows) revealed a strong expression of VITO-1 in the caudal branchial arches (Figs.  3I,J) , in the caudal branchial cleft and in the cranial pharynx (Figs. 3J,K) . In the trunk the earliest expression of VITO-1 was observed in somites at E8.75 (Fig. 3) . Vibratome sections revealed that VITO-1 expression was restricted to the myotome. No expression was seen in the dermatome or in the dermomyotomal lips. Myotomal expression started in somite IX or X according to the nomenclature of Christ and Ordahl (1995) . A side by side comparison revealed that VITO-1 is expressed slightly later than the myogenic factor Myf-5 approximately at the same time as Myogenin (Fig. 3 and data not shown) and significantly earlier than MyoD.
At E9.5 VITO-1 transcripts were apparent at distinct locations within the branchial arches and branchial pouches I-III. Interestingly, we also identified VITO-1 transcripts in Rathkes pouch (Rathkes pocket), from which the pituitary gland originates (Fig. 3F) . At E9.5 the youngest somites that expressed VITO-1 was somite IX (Fig. 3E) . Expression was still restricted to the myotome (Fig. 3L) .
A very similar expression pattern of VITO-1 was observed at E10.5 with a prominent expression in somites and in the second pharyngeal pouch. In addition, at E10.5 VITO-1 expression was found in the two newly emerged caudal pharyngeal pouches (number three and four) from which the parathyroid glands and the ultimobranchial bodies emerge, respectively Figs. 4A-D). As shown in Fig. 4 , newly forming somites in the caudal part of E10.5 embryos were still negative for VITO-1. No expression was detected in the myogenic precursor cells migrating towards the limb buds but a weak expression of VITO-1 was found in muscle precursor cells that have already arrived in the fore limb bud (Fig. 4F) . At E11.5 expression of VITO-1 was maintained in matured cranial somites and in presumptive muscle forming areas of the fore and hind limbs (Figs. 4G-I ). By E11.5 expression in the pharyngeal pouches had disappeared. From E12.5 onwards the strong expression in somites faded when myotomes dissipated and secondary muscle tissue formed (data not shown).
In summary, we demonstrated that VITO-1 is strongly expressed in the skeletal muscles lineage and in a transient dynamic pattern in pharyngeal pouches, pharyngeal endoderm and in Rathkes pouch.
Materials and methods

cDNA representational difference analysis
To identify new genes specifically expressed in human skeletal muscle a cDNA representational difference analysis protocol was adapted, which has originally been described by Hubank and Schatz (1994) . Subtractive hybridization was performed by incubating driver (fetal human heart cDNA) and tester DNA (fetal human skeletal muscle) in a 100:1 ratio as described (Hubank and Schatz, 1994) . After two rounds of subtraction using fetal liver cDNA as driver three additional subtraction rounds were performed with fetal heart cDNA as driver (100:1). The PCR fragments from the subtraction procedure were cloned into pGEMTeasy (Promega) and used to screen a human fetal muscle cDNA library in lgt11.
Northern-blot analysis
Isolation of total RNA, denaturation of RNA with glyoxal, gel electrophoresis, and Northern transfer on Pal Biodyne A membrane were done according to standard procedures. Fetal samples were derived from a fetus of 22 weeks of gestation. Adult human skeletal muscle samples were obtained from a patient undergoing leg amputation. Equal amounts of RNA were electrophoresed in each lane as assessed by ethidium bromide staining of ribosomal RNA and hybridization with a GAPDH probe. Hybridization was performed with a P 32 -labelled random primed murine 1 kbp XhoI/Sac1 cDNA fragment and a human 900 bp EcoRI cDNA fragment.
Whole-mount in situ hybridization
Whole-mount in situ hybridization on stages CD1 mouse embryos with digoxigenin labeled antisense cRNA probes, embedding and sectioning of stained embryos were performed as described previously (Kaul et al., 2000; Kruger et al., 2001 ); An antisense RNA-probe was generated by cloning a 1 kbp XhoI/SacI into the vector pKSII, linearization with XhoI, and transcription with T3 RNA polymerase. After staining embryos were embedded in gelatine and sectioned on a Vibratome at 20 mm.
